Avelumab in locally advanced or metastatic solid tumors
James L. Gulley
Can nivolimumab aid in preventing gastrointestinal cancer progression?
Ronan Joseph Kelly
Phase 1 study of anti-PD-L1 durvalumab plus gefitinib in TKI-naïve patients with EGFR-mutant NSCLC
Biomarkers and lung cancer: Current status
Overview of global immune checkpoint inhibitor studies